Search clinical trials for: Alopecia universalis

Total 526 results

Erasmus Medical Center

Recruiting

Systemic Treatments for Alopecia Areata Registry (STA2R)

Autoimmune Diseases | Alopecia | Alopecia Areata | Hair Diseases | Alopecia Totalis | Alopecia Universalis | Hair Loss | Alopecia Drugs

Netherlands
Throne Biotechnologies Inc.

Recruiting

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Pfizer

Terminated

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA (Allegro2a)

Alopecia Areata

United States, Australia, Canada, Poland
Equillium
Equillium AUS Pty Ltd

Completed

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata

Alopecia | Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Australia, New Zealand
Jinnah Hospital

Completed

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Pakistan
Pfizer

Active, not recruiting

Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-LT)

Alopecia Areata

United States, Spain, China, Korea, Republic of, Taiwan, Australia, Canada, Germany, Czechia, Poland, Japan, United Kingdom, Mexico, Argentina, Chile, Colombia, Russian Federation
Pfizer
In Expanded Access, treating physicians are the Sponsors

Available

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Alopecia Areata
Faculty Hospital Kralovske Vinohrady

Completed

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Infections | Multiple Sclerosis | Autoimmune Diseases | Diabetes Mellitus, Type 1 | Rheumatoid Arthritis | Vaccine Reaction | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Down Syndrome | Atopic Dermatitis | Vitiligo | Alopecia Areata | COVID-19 Pandemic | Ankylosing Spondylitis | Lupus Erythematosus and other conditions

Czechia
Equillium

Withdrawn

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis
Icahn School of Medicine at Mount Sinai
Sanofi; Regeneron Pharmaceuticals; Rockefeller University

Completed

Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)

Alopecia Areata

United States
Institute of Dermatology, Thailand

Completed

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Alopecia Areata

Thailand
Lindsey Bordone

Withdrawn

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis
Pfizer

Completed

PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-2b/3)

Alopecia Areata

China, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
Incyte Corporation

Terminated

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Alopecia Areata

United States
Aclaris Therapeutics, Inc.

Terminated

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
City, University of London
Royal Free Hospital NHS Foundation Trust

Completed

A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia

Alopecia

United Kingdom
Aclaris Therapeutics, Inc.

Completed

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Alopecia

United States
Aclaris Therapeutics, Inc.

Completed

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Alopecia Totalis (AT) | Alopecia Universalis (AU)

United States
Emma Guttman

Completed

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Aclaris Therapeutics, Inc.

Completed

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
M.D. Anderson Cancer Center
National Alopecia Areata Foundation

Active, not recruiting

Alopecia Areata Registry (NAAR)

Alopecia Areata | Alopecia Totalis | Alopecia Universalis | Autoimmune Hair Loss | Alopecia Partialis

United States
Columbia University
Locks of Love

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Alopecia Areata

United States
Yale University

Completed

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
University Hospital, Gentofte, Copenhagen

Completed

Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus

Pain Management

Denmark
Stanford University

Completed

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Yale University

Completed

Tofacitnib for the Treatment of Alopecia Areata and Variants

Alopecia Areata (AA) | Alopecia Totalis (AT) | Alopecia Universalis (AU)

United States
Northwestern University
Genentech, Inc.

Withdrawn

Efalizumab in the Treatment of Alopecia, Phase II

Alopecia Totalis
Julian M. Mackay-Wiggan

Withdrawn

Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis

Alopecia Totalis/Universalis
M.D. Anderson Cancer Center
Ligand Pharmaceuticals

Completed

Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

Alopecia Areata

United States
Siriraj Hospital

Completed

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Recalcitrant Alopecia Totalis | Recalcitrant Alopecia Universalis

Thailand
King Saud University
Saudi Society of Dermatology and Dermatologic surgery

Completed

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Alopecia Totalis | Alopecia Universalis | Ophiasic Alopecia

Saudi Arabia
Sanofi

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Alopecia Areata
Siriraj Hospital

Recruiting

The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients (PRF)

Platelet-rich Fibrin | Platelet-Rich Plasma | Female Pattern Hair Loss

Thailand
Assiut University

Not yet recruiting

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Pelage Pharmaceuticals, Inc.

Recruiting

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Androgenetic Alopecia

United States
Nutraceutical Wellness Inc.

Recruiting

Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females

Hair Thinning

United States
Nutraceutical Wellness Inc.

Recruiting

Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men

Hair Thinning

United States
Ache Laboratorios Farmaceuticos S.A.

Not yet recruiting

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss (CAPELLI)

Alopecia
Nektar Therapeutics

Recruiting

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Alopecia Areata

United States, Canada
Sohag University

Recruiting

Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss

Female Pattern Baldness | Dermatology

Egypt
Zagazig University

Recruiting

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Alopecia Areata

Egypt
Sohag University

Not yet recruiting

Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia

Androgenic Alopecia
Universitätsklinikum Hamburg-Eppendorf
German Federal Ministry of Education and Research

Not yet recruiting

Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases (DEVISE)

Psoriasis | Atopic Dermatitis | Vitiligo | Hidradenitis Suppurativa | Alopecia Areata

Germany
Blueskin AS

Recruiting

A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo (Derma-001)

Psoriasis | Atopic Dermatitis | Vitiligo | Alopecia Areata

Denmark
Universiti Tunku Abdul Rahman

Not yet recruiting

Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study

Alopecia | Androgenic Alopecia
Pfizer

Recruiting

Litfulo Capsules Special Investigation

Alopecia Areata

Japan
AI Labs Group S.L
Instituto de Dermatología Integral (IDEI)

Recruiting

Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions (IDEI_2023)

Acne Vulgaris | Acne | Alopecia, Androgenetic | Pigmented Lesions | Pigmented Skin Lesion

Spain
University of Alabama at Birmingham
Eli Lilly and Company

Recruiting

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Frontal Fibrosing Alopecia

United States
Services Hospital, Lahore

Recruiting

Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia

Androgenetic Alopecia

Pakistan
Egymedicalpedia

Recruiting

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

Alopecia Areata

Egypt

Search clinical trials for: Alopecia universalis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations